Investment archive

Investment feed — page 15

Back to latest investments

Daylight Security raises $80M Series B led by Goldman Sachs Alternatives

Daylight Security raises $80M Series B led by Goldman Sachs Alternatives

Daylight issuer confirmed $80M November 10 2026 Series B led Goldman Sachs Alternatives, $120M lifetime equity, Okta Ventures and returning Bain Craft Vintage Maple. The Wall Street Journal separately reported an approximate $400M valuation; issuer itself did not disclose valuation terms. $40x reported revenue growth has no audited base.

BKN301-owned Planky raises €6.9M to build AI credit decisioning

BKN301-owned Planky raises €6.9M to build AI credit decisioning

UK-based Planky, acquired by BKN301 Group in November 2025, announced €6.9M new financing on November 10, 2026, co-led by Innovation Global and Azimut Venture Capital Digitech Europe funds. No formal seed/Series A stage, valuation or equity instrument confirmed; SM Capital and FNDX supported/advised the transaction but are not automatically equity investors. Parent BKN301's 2025 Series B/credit facility is distinct.

Garage raises $41M Series B led by Invus Opportunities

Garage raises $41M Series B led by Invus Opportunities

Garage Technologies, the New York municipal heavy-equipment marketplace (not AirGarage), announced a $41M Series B on November 10, 2026, led by Invus Opportunities. Fortune independently reported a company-supplied $225M valuation, with pre/post-money unspecified. Garage's $100M+ annualized equipment sales measure transaction volume, NOT company revenue. Cumulative funding described as about $60M; the dated $4.5M seed + $13.5M Series A + $41M Series B sum to $59M, a rounding gap not a new round.

Graphon Labs raises $35M Series A led by RRE Ventures for persistent AI-agent memory

Graphon Labs raises $35M Series A led by RRE Ventures for persistent AI-agent memory

Graphon Labs announced a $35M Series A November 10, 2026 led by RRE Ventures with HP, Energy Impact Partners, Hitachi Ventures and Gaia VC participating. The company previously raised $8.3M in seed, giving $43.3M cumulative. Hitachi Rail describes evaluation; 49ers describes exploring use; benchmark numbers are company-tested, not independent production results. Valuation undisclosed.

Nidus Technologies discloses $30M combined early-stage funding for defence factory robotics

Nidus Technologies discloses $30M combined early-stage funding for defence factory robotics

Nidus Technologies disclosed $30M in funding November 10, 2026, backed by Kleiner Perkins and Costanoa, among others. Costanoa confirms it backed an earlier pre-seed; company DID NOT break out pre-seed and seed amounts. This is one combined cumulative disclosure, NOT a $30M new seed and not proof of a specific closing date. Robot models automate precision wire-harness assembly; initial deployments and $1M+ four-month revenue are company claims.

SPARETECH raises $20M Series B co-led by Blume Equity and Insight Partners

SPARETECH raises $20M Series B co-led by Blume Equity and Insight Partners

German industrial spare-parts intelligence firm SPARETECH announced a $20M Series B November 10, 2026, co-led Blume Equity and Insight Partners, Headline participating. Company's aim to cut parts inventory 60% within three years is a target not measured achievement; separately vendor reports 20% average for selected customers. Historical 2021 €5M Seed and 2023 €10M Series A already disclosed on company's own history.

PuppyGraph raises $10M Series A for graph queries over existing enterprise data

PuppyGraph raises $10M Series A for graph queries over existing enterprise data

PuppyGraph announced a $10M Series A November 10, 2026; total disclosed funding is $15M including historical $5M Seed led by defy.vc. IMPORTANT: founder's first-party blog describes Particle Future as the lead and defy.vc as a participant, while a company-issued Business Wire release calls both leads. Treat investor leadership as issuer-language discrepancy, not a separately priced round. Graph traversals run over live enterprise data sources without copying rows; performance and 7x ARR growth are company claims. Valuation undisclosed.

General Translation discloses $27M across Seed and Series A; a16z leads latest round

General Translation discloses $27M across Seed and Series A; a16z leads latest round

On November 10, 2026, General Translation founder Archie McKenzie disclosed $27M raised ACROSS earlier Seed and Series A rounds. a16z led Series A, Upfront Ventures led the Seed; individual round amounts, final close dates and valuation were not given. Do NOT classify $27M as new Series A proceeds. Existing 2025 seed estimate in VCT is unverified legacy data; this cumulative figure must be counted only once.

PromptPath raises $12M Series A for dealership conversation coaching

PromptPath raises $12M Series A for dealership conversation coaching

Company-announced Nov 10, 2026 $12M Series A co-led FM Capital and Armory Square Ventures, with Automotive Ventures, Holman Ventures and dealerships participating. Product provides human agents real-time customer context and call-coaching prompts across dealership sales, finance and service; not an autonomous replacement of human staff. Valuation and historic equity total undisclosed.

EnVision Endoscopy closes $11.5M Series A after first 50 SimpleStitch cases

EnVision Endoscopy closes $11.5M Series A after first 50 SimpleStitch cases

Nov 10, 2026 $11.5M Series A led by Puma Venture Capital with UTEC, existing shareholder Olympus Corporation of the Americas and MassVentures. FDA cleared SimpleStitch in 2025 and 2026 limited commercial launch; company reports first 50 patient procedures at pilot sites, NOT a controlled efficacy trial. Valuation undisclosed.

Nanopath closes $25M Series B financing package including $2M grants

Nanopath closes $25M Series B financing package including $2M grants

Issuer describes a $25M Series B financing package announced November 10, 2026, including $2M in non-dilutive grants. Thus the $25M is NOT pure venture equity; ~$23M non-grant financing is an arithmetic inference, not an independently disclosed priced equity subtotal. Co-led Norwest and SV Health Investors Medtech Convergence Fund; Labcorp Venture Fund also participated. Vaginitis assay remains investigational, with FDA 510(k) study planned.

Charta Health raises $55M Series B led by Insight Partners

Charta Health raises $55M Series B led by Insight Partners

November 10, 2026 issuer-confirmed $55M Series B led by Insight Partners; Bain Capital Ventures, Madrona, South Park Commons and QuantumLight participated. Charta reported $85M lifetime capital, 10x revenue growth (base undisclosed), and expansion into payer-side chart audit/risk-adjustment. Valuation undisclosed. Its prior $22M Series A and $8.1M seed are historical, not additional November proceeds.